Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis
The company expects to report topline data from the study in the summer of 2020.
Read More
Category: Research
Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting
Median ACR CRISS score remains 0.95 at 25 months in systemic sclerosis OLE.
Read More
Cara Therapeutics Announces Completion of Interim Statistical Assessment and Small Increase in Target Enrollment for KALM-2 Phase 3 Global Trial of KORSUVA™ Injection in Hemodialysis Patients with Pruritus
Patient enrollment increased approximately 20% to maintain >90% statistical power.
Read More
PURA – Puration Announces New Comprehensive Analyst Research Report on CBD Business and CBD Industry
The recent update confirmed Goldman’s original research recommendations.
Read More
PURA – Puration Schedules To Release CBD Infused Beverage Market Survey Results On Wednesday, September 18, 2019 As First Step In CBD Beer Coffee and Tea Marketing
The survey is part of a pre-marketing campaign of PURA’s new CBD Infused beer, coffee and tea beverages.
Read MoreGET LISTED
